Macrovascular involvement in scleroderma has received relatively little attention. We hereby describe a 5.6-cm ascending aortic aneurysm in a 56-year-old man presenting with increased dyspnea, diagnosed with antibody-negative, rapidly progressive diffuse cutaneous scleroderma. The patient had sclerosis and induration of all extremities, face, thorax and abdomen. Other features included Raynaud’s phenomenon, arthralgia, dysphagia, dyspnea attributed to pulmonary fibrosis, pericardial effusion, and cardiomyopathy. To the best of our knowledge, there is only one other report to date in the English language of a thoracic aortic aneurysm associated with scleroderma.
Aneurysm Aorta Scleroderma Systemic sclerosis
This is a preview of subscription content, log in to check access.
Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23(5):581–590CrossRefGoogle Scholar
Nadashkevich O, Davis P, Fritzler M (2004) A proposal of criteria for the classification of systemic sclerosis. Med Sci Monit 10(11):CR615–CR621PubMedGoogle Scholar
Abraham DJ, Varga J (2005) Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol 26(11):587–595CrossRefPubMedGoogle Scholar
Bickerstaff LK, Pairolero PC, Hollier et al (1982) Thoracic aortic aneurysms: a population-based study. Surgery 92:1103–1108PubMedGoogle Scholar
Crawford ES, DeNatale RW (1986) Thoracoabdominal aortic aneurysm: observations regarding the natural course of the disease. J Vasc Surg 3(4):578–582CrossRefPubMedGoogle Scholar